Related Experiment Videos
Conjunctivitis associated with methicillin-resistant Staphylococcus aureus in a long-term-care facility
The American Journal of Medicine
|May 1, 1990
Summary
Conjunctivitis linked to methicillin-resistant Staphylococcus aureus (MRSA) commonly affects patients with severe neurologic impairment in long-term care facilities. Both oral ciprofloxacin and topical vancomycin effectively treated MRSA conjunctivitis, though MRSA colonization often persisted.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Geriatric Medicine
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen in healthcare settings.
- Conjunctivitis is an ocular infection that can be caused by various microorganisms.
- Long-term-care facilities (LTCFs) are prone to endemic infections due to vulnerable patient populations.
Purpose of the Study:
- To characterize the clinical presentation of conjunctivitis caused by MRSA.
- To identify risk factors and outcomes associated with MRSA conjunctivitis in an LTCF setting.
Main Methods:
- A retrospective study followed 20 episodes of MRSA-associated conjunctivitis in 19 patients over three years.
- Data collected included patient demographics, clinical signs, MRSA colonization status, and treatment outcomes.
Main Results:
- The study identified purulent conjunctivitis as the primary clinical manifestation of MRSA infection.
- Seventeen patients (89%) had severe pre-existing neurologic impairment, and nine (47%) were previously colonized with MRSA.
- Clinical resolution was achieved in 7 of 8 patients treated with oral ciprofloxacin and all 8 patients treated with topical vancomycin.
Conclusions:
- MRSA-associated conjunctivitis predominantly affects individuals with severe neurologic conditions in LTCFs.
- Both oral ciprofloxacin and topical vancomycin demonstrated efficacy in resolving MRSA conjunctivitis.
- Increased recognition of MRSA conjunctivitis is anticipated given its endemic nature in LTCFs.